Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Developing a Human-Based Chimeric Retinal Organoid Model for use in Stem Cell Treatment Discovery for Inherited Retinal Diseases
FY 2022-23
Summary
Inherited retinal diseases (IRDs) are blinding eye conditions that affect approximately 85,000 Canadians and cost society $1.6-6.7 billion annually. Light-sensitive cells in the retina, called photoreceptors, progressively degenerate, leading to permanent blindness. There are currently no cures--but stem cell therapy holds exciting promise. Healthy cells from human donors are injected into a patient’s eye, replacing and repairing diseased photoreceptors. To progress treatment discovery, a new, human-based model in which to evaluate stem cell therapy is needed, as commonly used animal models do not faithfully mimic the human IRD condition. Retinal organoids are 3D retinal structures grown in a Petri dish from a single human stem cell lineage, induced to develop into mature retinal tissue. As a humanised model, organoids are ideal candidates for use in pre-clinical treatment discovery. My project aims to develop a novel retinal organoid model of transplantation to investigate the interactions between diseased host retinal cells and healthy donor retinal cells that promote vision restoration. By combining healthy stem cells and patient-derived IRD stem cells together, I will create mature mixed-lineage retinal organoids that reflect the clinical transplanted human retina. Throughout organoid development, I will use molecular assays to analyze the health of the organoid’s photoreceptors and evaluate potential structural and genetic changes. Creation of this innovative model will allow me to obtain new insight into donor-host cell interactions and photoreceptor rescue in a diseased retinal environment. This will provide a key step in understanding retinal stem cell transplantation and furthering stem cell treatment discovery for IRDs.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486596
Name
Ashworth Kristen E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Developing a Human-Based Chimeric Retinal Organoid Model for use in Stem Cell Treatment Discovery for Inherited Retinal Diseases
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Differentiation; Genetic Mutation; Inherited Retinal Disease; Organoid; Regenerative Medicine; Retina; Retinitis Pigmentosa; Rod Photoreceptor; Stem Cell; Stem Cell Transplantation
Abstract
Inherited retinal diseases (IRDs) are blinding eye conditions that affect approximately 85,000 Canadians and cost society $1.6-6.7 billion annually. Light-sensitive cells in the retina, called photoreceptors, progressively degenerate, leading to permanent blindness. There are currently no cures--but stem cell therapy holds exciting promise. Healthy cells from human donors are injected into a patient’s eye, replacing and repairing diseased photoreceptors. To progress treatment discovery, a new, human-based model in which to evaluate stem cell therapy is needed, as commonly used animal models do not faithfully mimic the human IRD condition. Retinal organoids are 3D retinal structures grown in a Petri dish from a single human stem cell lineage, induced to develop into mature retinal tissue. As a humanised model, organoids are ideal candidates for use in pre-clinical treatment discovery. My project aims to develop a novel retinal organoid model of transplantation to investigate the interactions between diseased host retinal cells and healthy donor retinal cells that promote vision restoration. By combining healthy stem cells and patient-derived IRD stem cells together, I will create mature mixed-lineage retinal organoids that reflect the clinical transplanted human retina. Throughout organoid development, I will use molecular assays to analyze the health of the organoid’s photoreceptors and evaluate potential structural and genetic changes. Creation of this innovative model will allow me to obtain new insight into donor-host cell interactions and photoreceptor rescue in a diseased retinal environment. This will provide a key step in understanding retinal stem cell transplantation and furthering stem cell treatment discovery for IRDs.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ashworth, Kristen E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~